Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$400K Buy
16,057
+2,400
+18% +$60.5K 0.24% 50
2025
Q3
$348K Sell
13,657
-17
-0.1% -$420 0.21% 60
2025
Q2
$331K Hold
13,674
0.2% 61
2025
Q1
$346K Buy
+13,674
New +$358K 0.23% 57

Other funds holding PFE

Pandora Wealth's PFE Position: Q4 2025 in Review

Pandora Wealth increased its Pfizer (PFE) stake by 18% in Q4 2025, buying an estimated $60.5K and bringing the position to 16,057 shares worth $400K. The position accounts for 0.24% of the portfolio, ranked #50.

Pandora Wealth first reported a position in PFE in Q1 2025 and has held it in 4 quarters since. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Pandora Wealth held 16,057 shares of Pfizer worth $400K as of Q4 2025.
  • Pandora Wealth bought 2,400 Pfizer shares in Q4 2025, an estimated $60.5K.
  • Pfizer made up 0.24% of Pandora Wealth's portfolio in Q4 2025, its #50 holding.
  • Pandora Wealth first reported a position in Pfizer in Q1 2025 and has held it in 4 quarters since.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.